Q fever: Difference between revisions

Jump to navigation Jump to search
Line 36: Line 36:
==[[Q fever medical therapy|Medical Therapy]]==
==[[Q fever medical therapy|Medical Therapy]]==
==[[Q fever primary prevention|Primary Prevention]]==
==[[Q fever primary prevention|Primary Prevention]]==
== Other ==
Because of its route of infection it can be used as [[biological warfare]] agent. See also bioterrorism.Q-fever is category "B" agent. It is highly contagious and very stable in aerosols in a wide range of temperatures. Just 1-2 particles are enough to infect an individual. Q-fever microorganisms may survive on surfaces up to 60 days (like sporulating bacteria) and C. burnetii is known to reproduce and grow well in chicken egg embryos reaching very high concentrations. Protection against disease is offered by Q-Vax, a whole cell inactivated vaccine developed by a leading Australian vaccine manufacturing company CSL.
(http://www.csl.com.au/QFever.asp)


== Acknowledgements ==
== Acknowledgements ==

Revision as of 15:09, 2 February 2012

For patient information click here

Q fever
Organism Responsible for Q fever, Rocky Mountain Laboratories, NIAID, NIH
ICD-10 A78
ICD-9 083.0
MeSH D011778

Q fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Q fever from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary prevention

Secondary prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Q fever On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Q fever

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Q fever

CDC on Q fever

Q fever in the news

Blogs on Q fever

Directions to Hospitals Treating Q fever

Risk calculators and risk factors for Q fever

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Historical perspective

Epidemiology & Demographics

Pathophysiology

History & Symptoms

Diagnosis

Lab Tests

Natural history, Complications, and Prognosis

Treatment

Medical Therapy

Primary Prevention

Acknowledgements

List of contributors:

Pilar Almonacid

References

http://www.cdc.gov/ncidod/diseases/submenus/sub_q_fever.htm http://www.cdc.gov/ncidod/dvrd/qfever/index.htm http://www.cdc.gov/healthypets/diseases/qfever.htm


  • Maurin M, Raoult D (1999). "Q fever". Clin. Microbiol. Rev. 12 (4): 518–53. PMID 10515901.


Template:Bacterial diseases cs:Q-horečka de:Q-Fieber hr:Q groznica it:Febbre Q he:קדחת Q nl:Q-koorts fi:Q-kuume

http://www.csl.com.au/QFever.asp


Template:WikiDoc Sources